WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareMedical Instruments & Supplies
Best Medical Stocks to Buy Now (2024)
Top medical stocks in 2024 ranked by overall Zen Score. See the best medical stocks to buy now, according to analyst forecasts for the medical instruments & supplies industry.

Industry: Medical Instruments & Sup...
Ticker
Company
Forecast Score
Market Cap
Price
Price Target
Upside/Downside
Top Analysts Upside/Downside
Consensus
Top Analysts Consensus
Analysts
Top Analysts
Fore. Revenue Growth
Fore. Earnings Growth
Forecast ROE
Forecast ROA
WST
WEST PHARMACEUTICAL SERVICES INC
$23.04B$316.34$460.3345.52%Strong Buy35.51%8.75%27.84%20.72%
RMD
RESMED INC
$29.95B$203.88$211.503.74%Buy68.05%21.15%30.37%20.63%
UTMD
UTAH MEDICAL PRODUCTS INC
$250.52M$71.00N/AN/AN/AN/AN/AN/AN/AN/A
ISRG
INTUITIVE SURGICAL INC
$147.61B$416.14$451.008.38%Strong Buy1513.34%5.81%N/AN/A
ALC
ALCON INC
$44.50B$90.00$98.058.94%Strong Buy125.22%22.06%10.11%7.12%
LMAT
LEMAITRE VASCULAR INC
$1.91B$85.31$82.75-3.00%Strong Buy47.74%12.40%18.12%15.79%
ATR
APTARGROUP INC
$9.69B$146.28$169.0015.53%Strong Buy23.79%11.13%22.00%11.65%
BDX
BECTON DICKINSON & CO
$66.97B$231.74$281.5021.47%Strong Buy44.46%50.32%18.65%8.83%
HAE
HAEMONETICS CORP
$4.40B$86.59$114.6732.43%Buy35.78%37.15%32.02%14.00%
ATRC
ATRICURE INC
$1.19B$24.67$42.5072.27%Strong Buy612.82%N/A-4.35%-3.35%
COO
COOPER COMPANIES INC
$18.18B$91.32$116.7527.85%Strong Buy85.51%52.27%11.24%7.28%
MMSI
MERIT MEDICAL SYSTEMS INC
$4.96B$85.40$95.7812.15%Buy94.63%43.39%18.69%9.97%
OSUR
ORASURE TECHNOLOGIES INC
$313.59M$4.24$5.2523.82%Hold2-24.97%N/AN/AN/A
HOLX
HOLOGIC INC
$18.12B$77.66$87.6312.83%Strong Buy84.29%34.49%N/AN/A
TFX
TELEFLEX INC
$10.38B$220.27$258.7517.47%Buy44.70%38.49%19.00%11.44%
ATRI
ATRION CORP
$803.56M$456.58N/AN/AN/AN/AN/AN/AN/AN/A
NEPH
NEPHROS INC
$22.88M$2.17$5.00130.41%Buy1N/AN/AN/AN/A
MHUA
MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES CO LTD
$23.70M$0.99N/AN/AN/AN/AN/AN/AN/AN/A
STAA
STAAR SURGICAL CO
$2.12B$43.14$46.337.40%Buy69.80%5.45%7.19%5.74%
RGEN
REPLIGEN CORP
$7.13B$127.63$195.5053.18%Strong Buy410.09%173.28%8.04%5.56%
STVN
STEVANATO GROUP SPA
$6.42B$21.73$30.0038.06%Buy25.57%7.64%15.39%9.25%
NYXH
NYXOAH SA
$261.21M$9.11$17.8095.45%Strong Buy5157.74%N/A-15.60%-12.04%
PDEX
PRO DEX INC
$65.82M$19.25N/AN/AN/AN/AN/AN/AN/AN/A
BAX
BAXTER INTERNATIONAL INC
$18.18B$35.68$41.3815.96%Hold82.83%-12.64%23.88%7.02%
XRAY
DENTSPLY SIRONA INC
$5.48B$26.41$33.2525.90%Buy82.18%N/A19.50%8.92%
ZJYL
JIN MEDICAL INTERNATIONAL LTD
$571.20M$3.57N/AN/AN/AN/AN/AN/AN/AN/A
EKSO
EKSO BIONICS HOLDINGS INC
$23.63M$1.30$6.25380.77%Strong Buy225.69%N/AN/AN/A
FEMY
FEMASYS INC
$24.66M$1.11$11.67951.08%Strong Buy3208.06%N/A-11.39%-7.29%
EMBC
EMBECTA CORP
$769.90M$13.35$12.00-10.11%Strong Sell1-0.21%25.37%N/AN/A
SMTI
SANARA MEDTECH INC
$250.99M$29.10$44.0051.20%Strong Buy1N/AN/A-15.74%-9.61%
AKYA
AKOYA BIOSCIENCES INC
$119.02M$2.41$6.70178.01%Strong Buy517.00%N/A-27.66%-5.85%
BLFS
BIOLIFE SOLUTIONS INC
$987.36M$21.45$24.3313.44%Strong Buy31.45%N/AN/AN/A
LUCY
INNOVATIVE EYEWEAR INC
$5.43M$6.20$20.00222.58%Strong Buy1N/AN/AN/AN/A
OMIC
SINGULAR GENOMICS SYSTEMS INC
$19.76M$8.00$10.7534.38%Hold2-19.68%N/AN/AN/A
BNGO
BIONANO GENOMICS INC
$41.18M$0.62$4.00549.35%Strong Buy2N/AN/AN/AN/A
WRBY
WARBY PARKER INC
$1.91B$16.08$16.00-0.50%Hold410.54%N/AN/AN/A
HBIO
HARVARD BIOSCIENCE INC
$138.11M$3.18N/AN/AN/AN/A9.19%N/AN/AN/A
NXGL
NEXGEL INC
$13.08M$2.10N/AN/AN/AN/AN/AN/AN/AN/A
MLSS
MILESTONE SCIENTIFIC INC
$65.64M$0.85N/AN/AN/AN/AN/AN/AN/AN/A
KRMD
KORU MEDICAL SYSTEMS INC
$115.78M$2.53$4.0058.10%Strong Buy113.08%N/A-2.39%-1.66%
AZTA
AZENTA INC
$2.90B$53.83$67.0024.47%Buy54.13%N/A2.16%1.87%
MBOT
MICROBOT MEDICAL INC
$15.55M$1.08$7.00548.15%Buy1N/AN/A-121.41%-101.64%
ICUI
ICU MEDICAL INC
$3.00B$123.19$135.509.99%Strong Buy20.69%N/A6.00%2.89%
POAI
PREDICTIVE ONCOLOGY INC
$4.80M$1.17N/AN/AN/AN/AN/AN/AN/AN/A
INFU
INFUSYSTEM HOLDINGS INC
$143.10M$6.72N/AN/AN/AN/AN/AN/AN/AN/A
BLCO
BAUSCH & LOMB CORP
$5.95B$16.93$18.7910.96%Buy76.25%N/A6.47%3.24%
ZTEK
ZENTEK LTD
$104.85M$1.04N/AN/AN/AN/AN/AN/AN/AN/A
POCI
PRECISION OPTICS CORPORATION INC
$36.53M$6.02N/AN/AN/AN/AN/AN/AN/AN/A
STSS
SHARPS TECHNOLOGY INC
$3.37M$0.22N/AN/AN/AN/AN/AN/AN/AN/A
PLSE
PULSE BIOSCIENCES INC
$906.80M$16.42N/AN/AN/AN/AN/AN/AN/AN/A
RVP
RETRACTABLE TECHNOLOGIES INC
$33.83M$1.13N/AN/AN/AN/AN/AN/AN/AN/A
AVGR
AVINGER INC
$3.00M$1.76$5.00184.09%Buy132.67%N/AN/A-5.15%
STXS
STEREOTAXIS INC
$164.46M$1.99$4.50126.13%Strong Buy2N/AN/AN/AN/A
ANGO
ANGIODYNAMICS INC
$278.38M$6.95$13.0087.05%Strong Buy3-0.91%N/A-5.31%-3.58%
GCTK
GLUCOTRACK INC
$8.55M$1.56N/AN/AN/AN/AN/AN/AN/AN/A
NVST
ENVISTA HOLDINGS CORP
$2.84B$16.50$20.2122.51%Hold72.65%N/A6.68%4.22%

Medical Stocks FAQ

What are the best medical stocks to buy right now in Jul 2024?

According to Zen Score, the 3 best medical stocks to buy right now are:

1. West Pharmaceutical Services (NYSE:WST)


West Pharmaceutical Services (NYSE:WST) is the top medical stock with a Zen Score of 54, which is 26 points higher than the medical industry average of 28. It passed 20 out of 38 due diligence checks and has strong fundamentals. West Pharmaceutical Services has seen its stock lose -17.75% over the past year, underperforming other medical stocks by -6 percentage points.

West Pharmaceutical Services has an average 1 year price target of $460.33, an upside of 45.52% from West Pharmaceutical Services's current stock price of $316.34.

West Pharmaceutical Services stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering West Pharmaceutical Services, 66.67% have issued a Strong Buy rating, 0% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Resmed (NYSE:RMD)


Resmed (NYSE:RMD) is the second best medical stock with a Zen Score of 54, which is 26 points higher than the medical industry average of 28. It passed 21 out of 38 due diligence checks and has strong fundamentals. Resmed has seen its stock lose -7.8% over the past year, overperforming other medical stocks by 4 percentage points.

Resmed has an average 1 year price target of $211.50, an upside of 3.74% from Resmed's current stock price of $203.88.

Resmed stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Resmed, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Utah Medical Products (NASDAQ:UTMD)


Utah Medical Products (NASDAQ:UTMD) is the third best medical stock with a Zen Score of 50, which is 22 points higher than the medical industry average of 28. It passed 17 out of 38 due diligence checks and has strong fundamentals. Utah Medical Products has seen its stock lose -27.83% over the past year, underperforming other medical stocks by -16 percentage points.

What are the medical stocks with highest dividends?

Out of 10 medical stocks that have issued dividends in the past year, the 3 medical stocks with the highest dividend yields are:

1. Dentsply Sirona (NASDAQ:XRAY)


Dentsply Sirona (NASDAQ:XRAY) has an annual dividend yield of 2.27%, which is 1 percentage points higher than the medical industry average of 1.23%. Dentsply Sirona's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dentsply Sirona's dividend has shown consistent growth over the last 10 years.

Dentsply Sirona's dividend payout ratio of -134.9% indicates that its dividend yield might not be sustainable for the long-term.

2. Atrion (NASDAQ:ATRI)


Atrion (NASDAQ:ATRI) has an annual dividend yield of 1.93%, which is 1 percentage points higher than the medical industry average of 1.23%. Atrion's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Atrion's dividend has shown consistent growth over the last 10 years.

Atrion's dividend payout ratio of 82.3% indicates that its dividend yield is sustainable for the long-term.

3. Utah Medical Products (NASDAQ:UTMD)


Utah Medical Products (NASDAQ:UTMD) has an annual dividend yield of 1.68%, which is the same as the medical industry average of 1.23%. Utah Medical Products's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Utah Medical Products's dividend has shown consistent growth over the last 10 years.

Utah Medical Products's dividend payout ratio of 26.4% indicates that its dividend yield is sustainable for the long-term.

Why are medical stocks down?

Medical stocks were down -1.88% in the last day, and down -0.9% over the last week. Intuitive Surgical was the among the top losers in the medical instruments & supplies industry, dropping -2.37% yesterday.

Intuitive Surgical shares are trading higher after the company reported better-than-expected Q2 financial results.

What are the most undervalued medical stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued medical stocks right now are:

1. Utah Medical Products (NASDAQ:UTMD)


Utah Medical Products (NASDAQ:UTMD) is the most undervalued medical stock based on WallStreetZen's Valuation Score. Utah Medical Products has a valuation score of 71, which is 53 points higher than the medical industry average of 18. It passed 5 out of 7 valuation due diligence checks.

Utah Medical Products's stock has dropped -27.83% in the past year. It has underperformed other stocks in the medical industry by -16 percentage points.

2. Embecta (NASDAQ:EMBC)


Embecta (NASDAQ:EMBC) is the second most undervalued medical stock based on WallStreetZen's Valuation Score. Embecta has a valuation score of 57, which is 39 points higher than the medical industry average of 18. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -33.45% in the past year. It has underperformed other stocks in the medical industry by -22 percentage points.

3. Meihua International Medical Technologies Co (NASDAQ:MHUA)


Meihua International Medical Technologies Co (NASDAQ:MHUA) is the third most undervalued medical stock based on WallStreetZen's Valuation Score. Meihua International Medical Technologies Co has a valuation score of 43, which is 25 points higher than the medical industry average of 18. It passed 3 out of 7 valuation due diligence checks.

Meihua International Medical Technologies Co's stock has dropped -61.02% in the past year. It has underperformed other stocks in the medical industry by -49 percentage points.

Are medical stocks a good buy now?

55% of medical stocks rated by analysts are a strong buy right now. On average, analysts expect medical stocks to rise by 22.67% over the next year.

What is the average p/e ratio of the medical instruments & supplies industry?

The average P/E ratio of the medical instruments & supplies industry is 54.44x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.